These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4421783)

  • 1. Problems of particulate matter in sterile solid products for injection.
    Hammer HF
    Bull Parenter Drug Assoc; 1974; 28(5):205-16. PubMed ID: 4421783
    [No Abstract]   [Full Text] [Related]  

  • 2. [Microbiological purity of pharmaceutical forms non-necessarily sterile].
    J Pharm Belg; 1972; 27(6):670-82. PubMed ID: 4665014
    [No Abstract]   [Full Text] [Related]  

  • 3. Ampins--the problems of "clear solution" and of particle shedding.
    Ernerot L
    Acta Pharm Suec; 1968 Apr; 5(2):101-10. PubMed ID: 5673469
    [No Abstract]   [Full Text] [Related]  

  • 4. Membrane filtration during administration for elimination of glass particles from ampoules.
    Sandell E; Ernerot L
    Acta Pharm Suec; 1968 Apr; 5(2):111-3. PubMed ID: 5673470
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of gum on injection solutions. Foreign particles].
    van Damme PA
    Pharm Acta Helv; 1970 Sep; 45(9):564-71. PubMed ID: 5469386
    [No Abstract]   [Full Text] [Related]  

  • 6. Contamination of intravenous solutions by airborne microbes.
    Hansen JS; Hepler CD
    Am J Hosp Pharm; 1973 Apr; 30(4):326-31. PubMed ID: 4697656
    [No Abstract]   [Full Text] [Related]  

  • 7. USP perspectives on particle contamination of injectable products.
    Gallelli JF; Groves MJ
    J Parenter Sci Technol; 1993; 47(6):289-92. PubMed ID: 8120733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panel discussion: current status of plastics as packaging materials for sterile products. I. Plastics for packaging small volume parenterals.
    Kaufman S
    Bull Parenter Drug Assoc; 1968; 22(1):31-3. PubMed ID: 5636758
    [No Abstract]   [Full Text] [Related]  

  • 9. Problems of contamination, exposure, and pollution in freeze-drying biological products.
    LaSalle B
    Dev Biol Stand; 1976 Oct; 36():201-5. PubMed ID: 1030420
    [No Abstract]   [Full Text] [Related]  

  • 10. Microbial contamination of topical ointments.
    Wargo EJ
    Am J Hosp Pharm; 1973 Apr; 30(4):332-5. PubMed ID: 4697657
    [No Abstract]   [Full Text] [Related]  

  • 11. Basics of Sterile Compounding: Particulate Matter.
    Akers MJ
    Int J Pharm Compd; 2017; 21(5):395-404. PubMed ID: 29216617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particulate contamination in New Zealand intravenous solutions.
    Passl WJ; Waring JM
    N Z Med J; 1980 Mar; 91(655):177-9. PubMed ID: 6929987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process simulation testing for aseptically filled products. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1996; 50 Suppl 1():S1-16. PubMed ID: 9038088
    [No Abstract]   [Full Text] [Related]  

  • 14. Particulate contamination from siliconized rubber stoppers--a statistical evaluation.
    Li LC; Parasrampuria J; Tian Y
    J Parenter Sci Technol; 1993; 47(5):270-3. PubMed ID: 8263665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological control in the manufacture of sterile pharmaceutical products.
    Bühlmann X
    Pharm Acta Helv; 1971 Jul; 46(7):385-409. PubMed ID: 4934853
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency of microbial contaminated ampoules caused by aseptic filling procedures.
    Kristensen H
    Dev Biol Stand; 1974; 23():79-82. PubMed ID: 4459202
    [No Abstract]   [Full Text] [Related]  

  • 17. Contamination of semi-solid dosage forms by leachables from aluminium tubes.
    Haverkamp JB; Lipke U; Zapf T; Galensa R; Lipperheide C
    Eur J Pharm Biopharm; 2008 Nov; 70(3):921-8. PubMed ID: 18620051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane filter technique for sterilizing filtration and for partical removal, with particular reference to the removal of particles from parenteral solutions.
    Grubert G
    Dev Biol Stand; 1974; 23():19-27. PubMed ID: 4459196
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of particulate matter in intravenous solutions using the Coulter counter.
    Blaug SM; Sarabia RE
    Bull Parenter Drug Assoc; 1975; 29(2):74-88. PubMed ID: 1120215
    [No Abstract]   [Full Text] [Related]  

  • 20. Statistical concepts in the interpretation of sterility tests on influenza virus vaccine.
    André FE; van Strik R
    Dev Biol Stand; 1974; 23():157-64. PubMed ID: 4459190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.